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The human microbiome is important for health and plays a role in essential metabolic 
functions and protection from certain pathogens. Conversely, dysbiosis of the micro-
biome is seen in the context of various diseases. Recent studies have highlighted that 
a complex microbial community containing hundreds of bacteria colonizes the healthy 
urinary tract, but little is known about the human urinary viruses in health and disease. To 
evaluate the human urinary virome in the context of kidney transplantation (tx), variations 
in the composition of the urinary virome were evaluated in urine samples from normal 
healthy volunteers as well as patients with kidney disease after they had undergone 
kidney tx. Liquid chromatography-mass spectrometry/mass spectrometry analysis 
was undertaken on a selected cohort of 142 kidney tx patients and normal healthy 
controls, from a larger biobank of 770 kidney biopsy matched urine samples. In addition 
to analysis of normal healthy control urine, the cohort of kidney tx patients had biopsy 
confirmed phenotype classification, coincident with the urine sample analyzed, of stable 
grafts (STA), acute rejection, BK virus nephritis, and chronic allograft nephropathy. We 
identified 37 unique viruses, 29 of which are being identified for the first time in human 
urine samples. The composition of the human urinary virome differs in health and kidney 
injury, and the distribution of viral proteins in the urinary tract may be further impacted by 
IS exposure, diet and environmental, dietary, or cutaneous exposure to various insecti-
cides and pesticides.
Keywords: kidney transplantation, virome, urine, proteomics, biomarkers
inTrODUcTiOn
The human microbiome has been studied extensively in various biofluids, such as blood (1), urine 
(2–4), saliva (5, 6), cerebrospinal fluid (7), and bronchoalveolar lavage (8, 9), for its influence on 
human health and disease (10). Several reports on the assessment of microbiomes in different 
regions of human body have been reported including lung and gut (11–15). However, only little is 
known about the urinary microbiome and its changes in the context of kidney injury after kidney 
transplantation (tx) (16, 17). Most human microbiome studies have mapped 16S rRNA for bacterial 
profiling (18), and there is only a small body of data examining the urine virome (19, 20), and a single 
published study has used next-generation sequencing to map viral genomic components in the urine 
of kidney transplant patients (19).
Dysbiosis of the microbiome is associated with multiple diseases such as inflammatory bowel 
disease, colon cancer, obesity and pulmonary disease (21–25), but little is known about alterations of 
the virome in human body fluids, such as saliva, bronchoalverolar lavage and urine. It is recognized 
FigUre 1 | Source of samples. LC-MS based proteomics was performed on 
the 142 samples chosen: 37 with acute rejection (AR), 40 stable (STA), 39 
with chronic allograft nephropathy (CAN), 17 with BK virus nephritis, and 9 
healthy controls.
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that various components of the microbiome perform essential 
functions including biosynthesis of cofactors and vitamins, 
metabolism of essential compounds, and barrier protection from 
pathogens (26–28). Similar dysbiotic and protective functions 
may also be ascribed to the urine virome; hence, it is important 
to ascertain the composition of the human virome in health and 
disease. For purposes of this study, we chose to conduct these 
studies in urine in health and in the context of IS exposure after 
kidney tx, during stable kidney function and in the context of kid-
ney tx injury. The focus of the study was to evaluate the repertoire 
of viruses as determined by the peptides present in human urine 
and their perturbations after IS exposure and various causes of 
acute, chronic, and infectious kidney injury.
The microbiome changes over time and correlates with 
organism diversity. Microbiome analysis can be segregated into 
both structural analysis based on operational taxonomic units 
based on sequence phylogeny, and functional analysis based on 
metagenomics sequencing and proteomics (29, 30). Identified 
microbiota in different diseases can be further studied by cultiva-
tion, functional metagenomics, and multiplexed immunofluo-
rescence and in situ hybridization. The NIH human microbiome 
project has published the human microbiome in 15 body sites 
from 300 individuals (31).
MaTerials anD MeThODs
A total of 142 unique samples were evaluated from a biorepository 
containing 2016 collected by IRB approved informed consent 
from adult and pediatric samples from the kidney tx programs at 
Stanford University and University of California San Francisco, 
between urine samples of which 770 were accompanied with 
matched kidney tx bx with centralized pathology histology reads 
and compartment scores using the standardized Banff schema 
(32) for scoring kidney tx bx injury (Figure 1). The study was 
approved by The Human Research Protection Program of the 
University of California, San Francisco. The urine samples were 
phenotyped based on the matched kidney bx pathology into five 
groups: healthy control (HC; n = 9), Stable graft (STA; n = 40), 
acute rejection (AR; n  =  37), chronic allograft nephropathy 
(CAN; n = 39), and BK virus nephritis (BKVN; n = 17). Urine 
was centrifuged 2,000 × g at 4°C for 20 min to get rid of urine sedi-
ments. The supernatant was passed through a filer membrane of 
10 kDa to remove native peptides from intact proteins larger than 
10 kDa in size. The total protein was then trypsin digested and 
the resulting tryptic peptides were analyzed by LC-MS platform 
(Orbitrap Velos MS). The detail methods of protein preparation 
and analyses are reported elsewhere (33).
The MSGF plus customized algorithm generated by our group 
(https://omics.pnl.gov/software/ms-gf), was used to search MS/
MS spectra against the combined human protein sequence data-
base and the NCBI viral database. Peptides were initially identified 
from database searching applying the following criteria: MSGF 
spectrum E-value (a probability value of the peptide to MS/MS 
spectrum match with the lower value the higher probability to 
be correct match) to be <10-10, Peptide level Q-value (false 
discovery rate estimated by targeted-decoy database search) to 
be <0.01, and mass measurement error <10 ppm (±5 ppm). The 
decoy database searching methodology was used to confirm the 
final false discovery rate at the unique peptide level to be <1%. 
Due to the anticipated higher false discovery rate for peptides 
from viral proteins, a more stringent filtering criteria with MSGF 
spectrum E value to be <1E-13 was applied. The false discovery 
rate was estimated to nearly 0% based on the well-accepted target-
decoy searching strategy because no decoy hits were observed 
following this stringent cutoff. Data are shown as percentages and 
mean ± SD. Comparisons of different categories are done using 
ANOVA and p values of <0.05 are considered significant.
resUlTs
Our group has previously published a detailed analysis of 
biologically relevant human proteins in these urine samples 
collected from kidney transplant recipients with different graft 
injury phenotypes, as confirmed by matched kidney transplant 
histopathology on the biopsy, collected at the same time as the 
urine sample; this data has been deposited in the proteomic 
MassIVE repository (accession MSV000079262) and in the 
ProteomeXchange repository (accession PXD002761) (33). In 
this study, we only focused on the identification and analysis of 
viral proteins in the same cohort of kidney transplant patients, 
with the inclusion also of age- and gender-matched healthy 
control human urine samples to evaluate viral proteins in both 
health and kidney injury. It is important to note that of the total 
analyzed human and viral proteins in urine, viral proteins alone 
constitute <0.2% of the total identified proteins, highlighting 
the very low abundance of rather rare viral proteins in human 
urine, irrespective of the type of kidney injury, and irrespective 
of baseline immunosuppression usage.
The results presented in this paper come from viral peptide 
mapping, unlike genomic sequencing of viral components as 
reported by previous publications (19). As an initial analysis, we 
focus on the prevalence of urinary viral proteins specific to each 
kidney transplant phenotype of STA, AR, CAN, and BKVN, and 
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the variations noted over the healthy control urine virome. Urinary 
viral protein data for each sample was evaluated for sample abun-
dance relative to the mean level of that virus in the entire sampled 
population. We found that on an average, 22% (range 4–67%) of 
kidney transplant patients had different viral proteins detected 
in their urine, excluding patients with BKVN, where detection 
of the BK virus in urine is to be expected, as these patients have 
infection with BK virus in their urinary tract and in the kidney 
transplant. The distribution of different viral proteins in different 
tx injury states and normal health are shown in the prevalence 
heat map (Figure 2). Overall, a total of 57 viral proteins from 37 
unique viruses were identified, many of these being unexpected 
and previously not described as “commensals” in human urine. Of 
these unique viruses, 8 viruses were single-stranded RNA viruses, 
1 virus was a single-stranded RNA-RT virus, and 28 viruses were 
double-stranded DNA viruses (Table 1). Out of the 142 patients, 
all patients had at least one viral protein in their urine, with an 
average of 10.23 ± 4.57 viral proteins/sample.
Prevalence of human Urine Viral Proteins
The healthy control group examined had 20 unique viral proteins 
with a group average of 13.67 ±  1.32 viral proteins. Kidney tx 
patients with maintenance IS and stable kidney tx function had 
a statistically significant lower number of unique viruses in the 
group (8.08 ±  2.78; p =  7e-10) when compared to the healthy 
cohort (normal kidney function and a normal immune system), 
without any IS exposure. Nine new viral proteins are instead 
detected in the STA cohort compared to healthy controls, belong-
ing to the following viruses: Junin virus, Cotesia congregata 
bracovirus, Agrotis segetum nucleopolyhedrovirus, Psittacid 
herpesvirus 1, Pseudocowpow virus, Spodoptera frugiperda mul-
tiple nucleopolyhedrovirus, Japanese yam mosaic virus, Cowpea 
mottle virus, and Helicoverpa zea single nucleopolyhedrovirus. 
Kidney injury after tx (despite continued IS exposure), results in 
an overall increase in the number of unique viral proteins over the 
STA tx cohort, with a significant increase in urine viral proteins in 
the CAN patient group (11.46 ± 3.52; p = 8e-10), and the BKVN 
patient group (15.76 ± 5.65; p = 13.7e-10). The repertoire of urine 
viral proteins appears to be quite distinct in different tx injury cat-
egories (Figure 3). The prevalence of BKV viral proteins in urine 
increases to 60–70% in AR, 70–80% in patients in CAN, and 100% 
in patients with BKVN (Figure 2), highlighting that increasing 
abundance of the BK virus in urine may result from augmentation 
of IS, as seen in the AR category, and with greater time post-tx, as 
seen in the CAN category. BKVN urine samples show the maximal 
divergence of urinary viral proteins, as expected. Four viral pro-
teins that are consistently present in all other samples, inclusive of 
normal healthy controls (Canarypox virus, Tacaribe virus, Simian 
virus 12, Acidianus filamentous virus 8), are no longer observed 
in the BKVN cohort. As BKV is a DNA virus, we examined if the 
changes in the urinary virome are largely related to an emergence 
of new DNA viruses in BKVN. Five new viral proteins are noted 
only in the BKVN cohort (Ectropis obliqua nucleopolyhedrovirus, 
Fowl adenovirus D, Taura syndrome virus, Invertebrate iridescent 
virus 6, Gallid herpesvirus 2). 4/5 of BKVN cohort viruses were 
double-stranded DNA viruses (Table 1).
abundance of human Urine Viral Proteins
We next evaluated the abundance of different viral proteins across 
all tx patients and HC urine samples. Among the 37 unique viruses 
examined, the following viruses were the most abundant in STA 
IS patients (Acidianus filamentous virus 8, Agrotis segetum nucleo-
polyhedrovirus, BK polyomavirus, Canarypox virus, Cotesia 
congregata bracovirus, Cowpea mottle virus, Glossina pallidipes 
salivary gland, hypertrophy virus, Simian virus 12, Tacaribe virus), 
and increased abundance of the Marsellavirus is seen in both CAN 
and BKVN. Despite intrarenal infection with the BKV virus in 
BKVN patients, we observe that low levels of the BK virus are 
detected also in all examined tx categories and healthy controls, 
likely as the BK virus is a normal human urine commensal, with 
its persistence in the human uroepithelium at low levels in almost 
all examined HC and kidney tx patients is not unexpected.
DiscUssiOn
A study the role of the microbiome in organ transplantation 
(13, 17, 34) takes in to account of the impact of food intake, 
digestion, metabolism, and modulation; however, dysbiosis of 
microbiota due to the tx and IS medicines is a contributing factor 
that decreases in the baseline predominant microbes and also 
results in a loss of overall diversity, and the emergence of few new 
dominant microbial populations (35). A very interesting finding 
from this study is that only 8 out of the 37 viruses identified in 
this dataset have been previously described in humans, and many 
of these have also been described to be pathogenic. Human infec-
tions have been described with some of the identified viruses, 
suggesting that their presence in urine may be relate to the 
pathogenesis of general systemic or the underlying renal injury. 
Junin virus (an arenavirus) infections can result in clinical human 
disease inclusive of fever, as well as an entity known as Argentine 
hemorrhagic fever (36). Tacaribe virus is an arenavirus that can 
also cause human fevers and hemorrhagic disease (36). The 
HHV-6 virus is a highly prevalent virus in children and causes 
fever, diarrhea, and rashes (37). Rhinoviruses are single-stranded 
RNA viruses that are the most infectious agent in humans and 
the most likely culprit for the common cold (38). Acanthocystis 
turfacea chlorella virus 1 has been in 44% of healthy humans (39) 
and has only been described in the oropharynx and is not known 
to be pathogenic to humans. The Marseille virus is a nucleocy-
toplasmic large DNA virus that has been described in blood and 
stool of patient with nonfebrile lymphadenopathy (40).
The SV40 virus is a DNA polyoma virus that was likely intro-
duced into the human population through contaminated vac-
cines (41) and infection with this virus is frequently co-infected 
with BK virus infection, this being an almost invariant finding in 
the tx population. Recent studies have also highlighted the role 
of chronic SV40 infection with human cancers (42). Antibodies 
against the T antigen of SV40 cross reacts with the T antigens 
of BK and JC viruses, which are all in the polyoma virus family, 
and the SV40 stain is used for diagnosis of BK virus infection in 
BKVN. BK virus exposure, in the kidney, is seen in 90% of the 
normal population, and our data suggests that the urinary virome 
has traces of BK viral proteins in all the healthy controls sampled. 
FigUre 2 | Heatmap of prevalence by disease status. Heatmap of the percentage of patients, within each disease status, in which each virus was detected. Total 
number of unique viruses in each disease status: healthy control (HC) 20, stable 27, acute rejection (AR) 28, chronic allograft nephropathy (CAN) 32, and BK 32.
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Table 1 | Breakdown of unique viruses.
Virus Virus family Virus type host Described in humans Used as pesticide/insecticide
Acanthocystis turfacea Chlorella virus 1 Phycodnaviridae dsDNA Algae Yes No
Acidianus filamentous virus 8 Lipothrixviridae dsDNA Sulfo bacteria No No
Agrotis segetum nucleopolyhedrovirus Baculoviridae dsDNA Lepidoptera No No
Amsacta moorei entomopoxvirus Poxviridae dsDNA Butterfly No No
BK polyomavirus Polyomaviridae dsDNA Humans Yes No
Bovine herpesvirus 1 Herpesviridae dsDNA Cow No No
Bovine viral diarrhea virus Flaviviridae (+)ssRNA Cow No No
Canarypox virus Poxviridae dsDNA Canary No No
Cotesia congregata bracovirus Polydnaviridae dsDNA Wasp No No
Cowpea mottle virus Tombusviridae (+)ssRNA Cowpeas No No
Ectropis obliqua nucleopolyhedrovirus Baculoviridae dsDNA Butterfly No Yes
Euproctis pseudoconspersa nucleopolyhedrovirus Baculoviridae dsDNA Butterfly No Yes
Fowl adenovirus D Adenoviridae dsDNA Birds No No
Gallid herpesvirus 2 Herpesviridae dsDNA Chicken No No
Glossina pallidipes salivary gland hypertrophy virus Hytrosaviridae dsDNA Tsetse fly No No
Helicoverpa armigera nucleopolyhedrovirus Baculoviridae dsDNA Butterfly No Yes
Helicoverpa zea single nucleopolyhedrovirus Baculoviridae dsDNA Butterfly No Yes
Human herpesvirus 6B Herpesviridae dsDNA Humans Yes No
Invertebrate iridescent virus 6 Iridoviridae dsDNA Insects No No
Japanese yam mosaic virus Potyviridae (+)ssRNA Yam No No
Junin virus Arenaviridae (−)ssRNA Mice Yes No
Marseillevirus Marseilleviridae dsDNA Amoeba Yes No
Melanoplus sanguinipes entomopoxvirus Poxviridae dsDNA Grasshoppers No No
Paramecium bursaria Chlorella virus 1 Phycodnaviridae dsDNA Algae No No
Pseudaletia unipuncta granulovirus Baculoviridae dsDNA Moth No No
Pseudocowpox virus Poxviridae dsDNA Cow No No
Psittacid herpesvirus 1 Herpesviridae dsDNA Parrots No No
Rhinovirus A Picornaviridae (+)ssRNA Humans Yes No
Simian virus 12 Polyomaviridae dsDNA Baboons No No
Simian virus 40 Polyomaviridae dsDNA Humans Yes No
Soybean yellow mottle mosaic virus Tombusviridae (+)ssRNA Soybean No No
Spodoptera frugiperda multiple nucleopolyhedrovirus Baculoviridae dsDNA Lepidoptera No No
Swinepox virus Poxviridae dsDNA Boars No No
Tacaribe virus Arenaviridae (−)ssRNA Rodents Yes No
Taura syndrome virus Dicistroviridae (+)ssRNA Shrimp No No
Trichoplusia ni ascovirus 2c Ascoviridae dsDNA Moths No No
Wooly monkey sarcoma virus Retroviridae ssRNA-RT Wooly Monkeys No No
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BK virus replication is seen in 10–60% of kidney tx patients have 
been described to shed BK virus in their urine, which is confirmed 
by our data (Figure 2). BK virus is latent in renal tubular epithelial 
cells and its prevalence is known to increase in immune dysfunc-
tion and immunosuppression exposure (43). In this study, we 
could not identify any urinary virome specific differences that 
could distinguish the AR and BKVN groups, despite these condi-
tions being immunologically distinct and requiring very different 
treatment approaches, i.e., minimization of immunosuppression 
in BKVN and increased immunosuppression in AR. The AR 
category was bx confirmed and there was negative SV40 stain in 
the bx tissue examined. Nevertheless, this data suggests that the 
detection of BKVN may be under-reported in kidney tx patients, 
and histological changes may be patchy resulting in BKVN dis-
ease underdiagnosis.
Of the remaining 19 viruses that have not been previously 
described in humans, the following have been noted to be used 
as pesticides/insecticides (E. obliqua nucleopolyhedrovirus, 
Euproctis pseudoconspersa nucleopolyhedrovirus, Helicoverpa 
armigera nucleopolyhedrovirus, H. zea single nucleopolyhedro-
virus). Pesticides in public health use are intended to limit the 
potential for disease but they have been known to make their 
way into human tissues/bodily fluids if not properly handled and 
that organic diets limit the amount of pesticides in children urine 
(44, 45). The finding of these viral proteins in human urine 
samples raises a question of environmental exposure to these 
previously undiscovered, possible contaminants.
The finding of 100% prevalence of some viruses only in the 
healthy control group suggests that there are viral commensals 
that may exist either without harm or may even be hypoth-
esized to assist in immune adaptation. Phylogentic tree analysis 
of these viruses may be interesting, as some viruses such as 
bacteriophages play an important role in health by removing 
pathogenic bacteria and helping boost innate immunity (16). 
A reduction in the protective viruses or phages may result in 
increased bacterial proliferation which is seen in the context 
of IS after kidney tx. Metagenomic sequencing of the new viral 
species found in tx patients under IS may identify if IS exposure 
has changed the resistance patterns or resistome of some of the 
viruses, especially those that are more prone to drive inflam-
mation and immunity (16). Silver nanoparticle treatment has 
been shown to reduce gut viral and bacterial populations that 
FigUre 3 | Boxplots of the number of unique viruses discovered by disease status. The boxplots show that the relative abundance of unique viruses discovered in 
stable and acute rejection (AR) patients is lower than the number discovered in healthy control (HC). The number of viruses discovered increased in chronic allograft 
nephropathy (CAN) above stable and AR. The number of viruses increased in BK over all immunosuppressed categories. T-Tests with Bonferroni corrections were 
used for multiple testing. *Significant at p < 0.05; **significant at p < 0.005; ***significant at p < 0.001.
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are pro-inflammatory (46). Mucinophilic microbiomes may be 
more prone to provide non-host protective immunity, and the 
loss of any mucinophilic viruses/microbes with IS may also be 
a driver of the increased risk of cystitis and urinary tract infec-
tions seen in patients after tx.
The microbiome intersects with states of health and disease. 
The novel detection of a large number of viruses used as pes-
ticides/insecticides is a surprising finding. Identification of 
viruses that are not expected to be present in the urine points 
to a possibility of their origin to enter bodily systems through 
ingestion (contamination of food, water, or other drinks such as 
milk) or cutaneous absorption (e.g., improper hand washing). In 
fact, according to federal law, a small residue of pesticides/insec-
ticide contamination of human food is recognized and accepted 
(41, 47), even though no one to date has examined their presence 
in urine. It is also possible that these viruses colonize or invade 
the urinary tract by ascending infection, especially in the context 
of IS in a kidney tx patient, where there is lowered host immune 
defense.
Further validation of these results by evaluation of the human 
virome repertoire in different geographic and demographic 
cohorts of patients with different causes of kidney injury will bet-
ter identify if the peculiar repertoire of viral proteins observed in 
this study is specific to a patient, their geography, their demogra-
phy, or the kidney disease subtype. Additional validation studies 
by urine viral PCR assays can provide for rapid assessment of the 
clinical impact of these viruses in other kidney injury cohorts. 
Interestingly, in the repertoire of identified viral peptides, we did 
not observe any phages. This is attributed to the methodology 
used for peptide preparation from urine supernatant, which does 
not capture bacteria (which get pelleted out), the host of phage 
viruses (48). The virome report based on DNA sequence analysis 
also did not identify phages in the published report (19). The urine 
virome study that used purified bacteriophage isolation using 
cesium chloride density gradient has reported identification of 
phages (20). These articles all support that the methodology of 
sample prep influences the eventual findings.
Colonization, resistance, and microbial ecology has been 
described and well studied in the context of microbial infections 
(49), and it has been shown that antibiotic treatment (in the con-
text of treating infections in the animals that form food products 
or as part of the antiviral prophylaxis for tx patients in the first 
3–6 months post-tx) eliminates many commensal bacterial and 
viral species form the gut and other body fluids and reduces 
antimicrobial defense (50). Colonization by microbiota in early 
life shapes the immune system and create a window of opportu-
nity for a homeostatic state, which if disrupted, in the context of 
tx and IS, can contribute to inflammation. Precision medicine 
approaches in the future may want to customize therapy from a 
“microbiota centered” and “host centered” approach to precision 
medicine. Until recently, we have not paid much attention to the 
food microbiome and the understanding that many emerging 
infections may be vectored by foods. Current efforts to develop a 
metagenome trackr tool that will evaluate the impact of different 
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